Relationship between pre-treatment nutritional status, serum glutamine, arginine levels and clinicopathological features in Taiwan colorectal cancer patients

Asia Pacific Journal of Clinical Nutrition

Volumn 24, Issue 4, 2015, Pages 598-604

  Pan, Yi Ping ^a   Chang, Pei Hung ^b   Fan, Chung Wei ^a   Tseng, Wen Ko ^a   Huang, Jen Seng ^b   Chen, Chih Hung ^b   Chou, Wen Chi ^b   Wang, Cheng Hsu ^b   Yeh, Kun Yun ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Arginine; Body weight loss; Glutamine; Hypoalbuminemia; Low BMI

Indexed keywords

ARGININE; C REACTIVE PROTEIN; GLUTAMINE;

AGED; BLOOD; BODY MASS; CANCER STAGING; COLORECTAL NEOPLASMS; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPOALBUMINEMIA; LENGTH OF STAY; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PATHOLOGY; TAIWAN; VERY ELDERLY; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ARGININE; BODY MASS INDEX; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLUTAMINE; HUMANS; HYPOALBUMINEMIA; LENGTH OF STAY; MALE; MALNUTRITION; MIDDLE AGED; NEOPLASM STAGING; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; TAIWAN; WEIGHT LOSS;

EID: 84983687002     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2015.24.4.23     Document Type: Article

References (25)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489-95. doi: 10.1016/S1470-2045(10)70218-7.
2. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63. doi:10.1016/S0140-6736(03)15268-3.
3. Pan H, Cai S, Ji J, Jiang Z, Liang H, Lin F et al. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals. Nutr Cancer. 2013;65:62-70. doi: 10.1080/01635581.2013.741752.
4. Chen Y, Liu BL, Shang B, Chen AS, Liu SQ, Sun W et al. Nutrition support in surgical patients with colorectal cancer. World J Gastroenterol. 2011;17:1779-86. doi: 10.3748/wjg.v17.i13.1779.
5. Dobrila-Dintinjana R, Trivanovic D, Zelic M, Radic M, Dintinjana M, Petranovic D et al. Nutritional support in patients with colorectal cancer during chemotherapy: does it work? Hepatogastroenterology. 2013;60:475-80. doi: 10.5754/hge12710.
6. Karlsson S, Andersson L, Berglund B. Early assessment of nutritional status in patients scheduled for colorectal cancer surgery. Gastroenterol Nurs. 2009;32:265-70. doi: 10.1097/SGA.0b013e3181aead68.
7. Medina MA. Glutamine and cancer. J Nutr. 2001;131:2539S-42S. doi: 10.1207/S15327914NC401_5.
8. Wang WS, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist. 2007;12:312-9. doi: 10.1634/theoncologist.12-3-312.
9. Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D et al. Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res. 2001;7:1192-7.
10. Ziegler TR. Glutamine supplementation in bone marrow transplantation. Br J Nutr. 2002;87(Suppl 1):S9-15. doi: 10.1079/BJN2001452.
11. Bozzetti F, Biganzoli L, Gavazzi C, Cappuzzo F, Carnaghi C, Buzzoni R et al. Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study. Nutrition. 1997;13:748-51. doi: 10.1016/S0899-9007(97)83038-9.
12. Lind DS. Arginine and cancer. J Nutr. 2004;134:2837S-41S.
13. Popovic PJ, Zeh HJ, 3rd, Ochoa JB. Arginine and immunity. J Nutr. 2007;137(6 Suppl 2):1681S-6S.
14. Vissers YL, Dejong CH, Luiking YC, Fearon KC, von Meyenfeldt MF, Deutz NE. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr. 2005;81:1142-6. doi: 10.1016/S0261-5614(03)80248-0.
15. Wheatley DN. Controlling cancer by restricting arginine availability--arginine-catabolizing enzymes as anticancer agents. Anticancer Drugs. 2004;15:825-33. doi: 10.1097/00001813-200410000-00002.
16. Mauricio SF, da Silva JB, Bering T, Correia MI. Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition. 2013;29:625-9. doi: 10.1016/j.nut.2012.09.016.
17. Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Prado CM et al. Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr. 2013;32:65-72. doi: 10.1016/j.clnu.2012.05.009.
18. Hsieh MC, Chin CC, Huang WS, Yeh CH, Kuo YH, Chen JS et al. Risk factors and postoperative morbidities in colon cancer patients with preoperative hypoalbuminemia. J Soc Colon Rectal Surgeon (Taiwan). 2012;23:6-12.
19. Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006;40:592-5. doi: 10.1097/00004836-200608000-00006.
20. Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, Lert-Akayamanee N. Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol. 2008;14:1248-51. doi: 10.3748/wjg.14.1248.
21. Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009;9:288. doi: 10.1186/1471-2407-9-288.
22. Melstrom LG, Melstrom KA Jr, Ding XZ, Adrian TE. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol. 2007;22:805-14.
23. Choi JS, Baek HM, Kim S, Kim MJ, Youk JH, Moon HJ et al. Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy. PLoS One. 2013;8:e8366. doi: 10.1371/journal.pone.0083866.
24. Qiu Y, Cai G, Zhou B, Li D, Zhao A, Xie G et al. A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res. 2014;20:2136-46. doi: 10.1158/1078-0432.CCR-13-1939.
25. Wang LB, Shen JG, Zhang SZ, Ding KF, Zheng S. Amino acid uptake in arterio-venous serum of normal and cancerous colon tissue. World J Gastroenterol. 2004;10:1297-300.